XML 54 R41.htm IDEA: XBRL DOCUMENT v3.26.1
SCHEDULE OF DISAGGREGATED BY PRODUCT (Details) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Disaggregation of Revenue [Line Items]    
Total revenues $ 56,325 $ 10,258
Losartan Potassium Oral Suspension [Member]    
Disaggregation of Revenue [Line Items]    
Total revenues 56,325
Pharmaceutical Product Resale [Member]    
Disaggregation of Revenue [Line Items]    
Total revenues $ 10,258